Suppr超能文献

帕金森病突变体E46K在哺乳动物细胞系、酵母和体内增强α-突触核蛋白的磷酸化。

Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.

作者信息

Mbefo Martial Kamdem, Fares Mohamed-Bilal, Paleologou Katerina, Oueslati Abid, Yin Guowei, Tenreiro Sandra, Pinto Madalena, Outeiro Tiago, Zweckstetter Markus, Masliah Eliezer, Lashuel Hilal A

机构信息

From the Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Station 15, 1015 Lausanne, Switzerland.

the Department of NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

出版信息

J Biol Chem. 2015 Apr 10;290(15):9412-27. doi: 10.1074/jbc.M114.610774. Epub 2015 Feb 5.

Abstract

Although α-synuclein (α-syn) phosphorylation has been considered as a hallmark of sporadic and familial Parkinson disease (PD), little is known about the effect of PD-linked mutations on α-syn phosphorylation. In this study, we investigated the effects of the A30P, E46K, and A53T PD-linked mutations on α-syn phosphorylation at residues Ser-87 and Ser-129. Although the A30P and A53T mutants slightly affected Ser(P)-129 levels compared with WT α-syn, the E46K mutation significantly enhanced Ser-129 phosphorylation in yeast and mammalian cell lines. This effect was not due to the E46K mutant being a better kinase substrate nor due to alterations in endogenous kinase levels, but was mostly linked with enhanced nuclear and endoplasmic reticulum accumulation. Importantly, lentivirus-mediated overexpression in mice also showed enhanced Ser-129 phosphorylation of the E46K mutant compared to WT α-syn, thus providing in vivo validation of our findings. Altogether, our findings suggest that the different PD-linked mutations may contribute to PD pathogenesis via different mechanisms.

摘要

尽管α-突触核蛋白(α-syn)磷酸化被认为是散发性和家族性帕金森病(PD)的一个标志,但对于与PD相关的突变对α-syn磷酸化的影响却知之甚少。在本研究中,我们调查了A30P、E46K和A53T这三种与PD相关的突变对α-syn第87位丝氨酸(Ser-87)和第129位丝氨酸(Ser-129)磷酸化的影响。与野生型(WT)α-syn相比,尽管A30P和A53T突变体对Ser(P)-129水平有轻微影响,但E46K突变在酵母和哺乳动物细胞系中显著增强了Ser-129的磷酸化。这种效应并非由于E46K突变体是更好的激酶底物,也不是由于内源性激酶水平的改变,而是主要与细胞核和内质网积累的增强有关。重要的是,与WT α-syn相比,慢病毒介导的在小鼠体内过表达也显示E46K突变体的Ser-129磷酸化增强,从而为我们的发现提供了体内验证。总之,我们的研究结果表明,不同的与PD相关的突变可能通过不同机制导致PD发病。

相似文献

1
Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.
J Biol Chem. 2015 Apr 10;290(15):9412-27. doi: 10.1074/jbc.M114.610774. Epub 2015 Feb 5.
3
Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
J Bioenerg Biomembr. 2010 Feb;42(1):85-95. doi: 10.1007/s10863-009-9258-y. Epub 2010 Feb 11.
4
Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
J Biol Chem. 2016 Feb 26;291(9):4374-85. doi: 10.1074/jbc.M115.705095. Epub 2015 Dec 30.
5
E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway.
Molecules. 2018 Nov 1;23(11):2839. doi: 10.3390/molecules23112839.
6
Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.
Mol Neurobiol. 2014 Oct;50(2):685-701. doi: 10.1007/s12035-014-8738-1. Epub 2014 May 16.
10
In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Neuroscience. 2014 Jan 3;256:72-82. doi: 10.1016/j.neuroscience.2013.09.061. Epub 2013 Oct 12.

引用本文的文献

2
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's disease.
Cell Rep. 2025 Mar 25;44(3):115355. doi: 10.1016/j.celrep.2025.115355. Epub 2025 Mar 7.
3
CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease.
NPJ Parkinsons Dis. 2024 Oct 23;10(1):194. doi: 10.1038/s41531-024-00801-3.
4
CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.
Autophagy. 2024 Feb;20(2):311-328. doi: 10.1080/15548627.2023.2256135. Epub 2024 Jan 25.
5
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
Life Sci Alliance. 2023 Aug 21;6(11). doi: 10.26508/lsa.202301985. Print 2023 Nov.
7
CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders.
Front Mol Biosci. 2022 Oct 6;9:916063. doi: 10.3389/fmolb.2022.916063. eCollection 2022.
9
Synuclein Analysis in Adult .
Int J Mol Sci. 2022 May 27;23(11):6058. doi: 10.3390/ijms23116058.

本文引用的文献

2
Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology.
Neurobiol Aging. 2014 Sep;35(9):2180.e1-5. doi: 10.1016/j.neurobiolaging.2014.03.024. Epub 2014 Mar 26.
4
The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
Biochemistry. 2013 Oct 8;52(40):6925-7. doi: 10.1021/bi400999d. Epub 2013 Sep 23.
5
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
Ann Neurol. 2013 Apr;73(4):459-71. doi: 10.1002/ana.23894.
6
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Mov Disord. 2013 Jun;28(6):811-3. doi: 10.1002/mds.25421. Epub 2013 Mar 1.
7
A novel α-synuclein missense mutation in Parkinson disease.
Neurology. 2013 Mar 12;80(11):1062-4. doi: 10.1212/WNL.0b013e31828727ba. Epub 2013 Feb 20.
8
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Acta Neuropathol. 2013 May;125(5):753-69. doi: 10.1007/s00401-013-1096-7. Epub 2013 Feb 12.
9
Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress.
Brain Res. 2013 Mar 15;1500:19-27. doi: 10.1016/j.brainres.2013.01.024. Epub 2013 Jan 18.
10
The many faces of α-synuclein: from structure and toxicity to therapeutic target.
Nat Rev Neurosci. 2013 Jan;14(1):38-48. doi: 10.1038/nrn3406.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验